Public Documents -
Personal Injury
Drug Injury Law: Cancer of The Pancreas: Possible Side Effect For Diabetics Who Use Byetta, Januvia, Or Victoza?
Diabetes Doctors And Drug Safety Watchdog Group Express More Concern Than Ever Following June 2013 BMJ Medical Journal Article
http://www.drug-injury.com/druginjurycom/2013/06/pancreatic-januvia-cancer-byetta-pancreas-victoza-safety-risks-increased-diabetes-medications-side-effects.html
Posted by
Tom
Lamb on
6.17.13
in
Personal Injury.
Drug Injury Watch: Summer 2013 Bayer Lawsuits Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits Continue To Be Settled, With New Cases Being Filed
Bayer Financial Report Shows That More Than 2,500 Venous / Blood Clot Cases (DVT and/or PE) Do Not Have Settlement Agreements As Of April 15, 2013
http://www.drug-injury.com/druginjurycom/2013/06/bayer-lawsuits-yaz-settlements-yasmin-deaths-ocella-blood-clots-gianvi-pe-beyaz-dvt-safyral-claims-injury-birth-control-side-.html
Posted by
Tom
Lamb on
6.11.13
in
Personal Injury.
Drug Injury Watch: Depakote Or Depakene Taken During Pregnancy May Cause Congenital Malformations Or Birth Defects Such As Neural Tube Defects Like Spina Bifida
In Addition, There Are FDA Warnings That Using Depakote Or Depakene While Pregnant May Put Child At Risk For Having A Lower IQ Score Later In Life
http://www.drug-injury.com/druginjurycom/2013/05/birth-defects-depakote-pregnancy-depakene-pregnant-spina-bifida-risks-lower-iq-scores-fda-warnings-2013.html
Posted by
Tom
Lamb on
6.4.13
in
Personal Injury.
Drug Injury Watch: October 2012 Infuse Bone Senate Investigation Report Criticizes Medtronic For "Ghostwriting" Of Numerous Medical Journal Articles
Apparently In Order To Boost Sales Of Infuse Bone Growth Product, Medtronic Hid Medical Complications Such As Etopic Bone Growth And Male Sterility
http://www.drug-injury.com/druginjurycom/2013/05/medtronic-infuse-2012-us-senate-investigation-medical-journals-ghostwriting-authors-conflicts-of-interests.html
Posted by
Tom
Lamb on
6.3.13
in
Personal Injury.
Drug Injury Watch: Infuse Bone Graft: Medtronic-Funded Studies Essentially Ignored Serious Medical Complications And Side Effects Associated With Its Back Surgery Product
A 2009 - 2012 Series Of Investigative Reports Published By The Milwaukee Journal Sentinel Exposed Various "Problems" With How Medtronic Went About Boosting Sales Of Infuse
http://www.drug-injury.com/druginjurycom/2013/05/medtronic-infuse-bone-graft-milwaukee-journal-sentinel-john-fauber-investigative-reporter-articles-series.html
Posted by
Tom
Lamb on
5.21.13
in
Personal Injury.
Drug Injury Watch: Medtronic Infuse Bone Graft Efficacy And Safety Study By Yale: Widely Anticipated Results Are Set To Be Released In June 2013
This Controversial Medtronic Spine Treatment Was Put In The Spotlight By June 2011 Medical Journal Articles About Serious Risks And Problems With Infuse
http://www.drug-injury.com/druginjurycom/2013/04/2013-yale-study-medtronic-infuse-bone-graft-safety-issues-off-label-use-medical-complications.html
Posted by
Tom
Lamb on
5.2.13
in
Personal Injury.
Drug Injury Watch: Mirena IUD Migrations And Perforations Requiring Surgical Removals Result In Growing Number Of Lawsuits Against Bayer
First Mirena Case Trial, Baugh v. Bayer, Scheduled To Start May 6, 2013 In South Carolina Federal District Court
http://www.drug-injury.com/druginjurycom/2013/04/mirena-law-legal-bayer-iud-lawsuits-device-migrations-perforations-surgical-removals.html
Posted by
Tom
Lamb on
4.23.13
in
Personal Injury.
Drug Injury Watch: Two Conferences About Big Pharma Conduct: One Past (Selling Sickness 2013), One Future (PharmedOut's 4th Annual Conference)
At Their Respective Websites, You Can See What You Have Missed And What You Can Look Forward To In Washington, DC
http://www.drug-injury.com/druginjurycom/2013/04/big-pharma-conferences-pharmedout-selling-sickness-2013-washington-dc-events.html
Posted by
Tom
Lamb on
4.18.13
in
Personal Injury.
Drug Injury Watch: Second Fosamax - Femur Fracture Lawsuit Trial Starts In New Jersey, This One In The Federal Court MDL With Judge Pisano Presiding
Still Waiting For The First Jury Verdict In A Fosamax Bellwether Trial Involving Femur Fractures, After The Su v. Merck Case Ended Suddenly In A Mistrial
http://www.drug-injury.com/druginjurycom/2013/04/glynn-merck-trial-jury-verdict-bellwether-test-case-trials-fosamax-femur-fractures-lawsuits.html
Posted by
Tom
Lamb on
4.10.13
in
Personal Injury.
Fate Of Affymax Anemia Drug Omontys Remains Uncertain As FDA And Drug Company Continue To Study Cause Of Drug Reactions
Fresenius Dialysis Clinics Decided To Stop Using Omontys Before FDA Warning Came Out Due To Five Adverse Event Reports From One Day In February 2013
http://www.drug-injury.com/druginjurycom/2013/04/omontys-anaphylaxis-peginesatide-allergic-hypersensitivity-reactions-anaphylactic-deaths-fresenius-dialysis-patients-fda-reca.html
Posted by
Tom
Lamb on
4.3.13
in
Personal Injury.